Reports for BAXTER CORPORATION
Company Name BAXTER CORPORATION |
||
|---|---|---|
Totals |
||
Shortage reports |
226 |
|
| Actual shortage: | 4 (2%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 3 (1%) | |
| Resolved: | 217 (96%) | |
Discontinuation Reports |
28 |
|
| To be discontinued: | 2 (7%) | |
| Discontinued: | 26 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
16 (6%) |
|
Overdue reports |
7 (88%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2020-03-10 | 2020-03-21 | 108434 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2020-03-12 | 2020-04-08 | 108635 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-09-17 | 150508 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-09-02 | 150511 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-08-24 | 150514 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-08-03 | 2022-09-02 | 165961 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-08-03 | 2022-08-30 | 165965 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-10-05 | 2022-10-26 | 171211 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-10-05 | 2022-12-01 | 171215 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-03-15 | 2023-03-31 | 187084 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-04-12 | 2023-04-29 | 189362 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-07-06 | 2023-07-31 | 197756 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-10-11 | 2023-10-24 | 206816 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2024-06-06 | 2024-12-02 | 229848 |
| 70% DEXTROSE INJECTION USP | 70G | SOLUTION | Resolved | 2021-10-13 | 2021-11-05 | 147116 |
| 70% DEXTROSE INJECTION USP | 70G | SOLUTION | Resolved | 2025-01-10 | 2025-03-11 | 247430 |
| ACETAMINOPHEN INJECTION | 10MG | SOLUTION | Resolved | 2024-08-07 | 2024-09-14 | 234740 |
| ACETAMINOPHEN INJECTION | 10MG | SOLUTION | Resolved | 2024-11-01 | 2025-01-09 | 241787 |
| AERRANE | 100% | LIQUID | Resolved | 2022-12-09 | 2023-01-17 | 177708 |
| AERRANE | 100% | LIQUID | Resolved | 2024-09-06 | 2024-10-23 | 236906 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLINIMIX | 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG 10G 365MG 280MG 290MG 200MG 300MG 290MG | SOLUTION | Discontinued | 2020-06-22 | 2022-04-20 | 118601 |
| CLINIMIX E | 205MG 261MG 58.5MG 24MG 16.6G 365MG 280MG 290MG 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG | SOLUTION | Discontinued | 2020-06-22 | 2022-06-30 | 118607 |
| CLINIMIX E | 90MG 210MG 20MG 261MG 58.5MG 24MG 205MG 20G 310MG 310MG 290MG 290MG 1.04G 1.04G 520MG 240MG 230MG 220MG 210MG | SOLUTION | Discontinued | 2020-06-22 | 2021-03-26 | 118604 |
| CLINOLEIC 20% | 4% 16% | EMULSION | Discontinued | 2017-04-04 | 2018-01-01 | 5289 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91385 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91382 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91378 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 900MG 300MG | SOLUTION | Discontinued | 2020-11-26 | 2021-02-02 | 128947 |